2016 WHO Classification of Tumors of Hematopoietic and Lymphoid Tissues

The 2016 WHO Classification of Tumors of Hematopoietic and Lymphoid Tissues is a detailed system used by doctors to identify and categorize blood-related cancers, such as leukemia, lymphoma, and myeloma. It combines information about cell appearance, genetic changes, and how the disease behaves to improve diagnosis and treatment. This system helps clinicians understand the specific type of blood cancer a patient has, which is essential for choosing the most effective therapy and predicting outcomes. Overall, it provides a standardized way for healthcare professionals worldwide to diagnose and study blood cancers accurately.